Company Name:ChemoCentryx Inc.
CEO: Thomas J. Schall

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: ChemoCentryx Inc is a biopharmaceutical company. It is engaged in discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer.


Key numbers

Market Capitalization:2544024540
Shares Outstanding: 58269000
Float: 40399762
Next Earning Date:2020-03-12
TTm EPS: -0.9235
TTm Dividend Rate:
200 days moving average:13.72
50 days moving average: 27.43
One day percent Change: -4.19



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,